Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
about
Molecular basis for recognition of the cancer glycobiomarker LacdiNAc (GalNAc(β1-4)GlcNAc) by Wisteria floribunda agglutininA proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation.Viral glycoproteins: biological role and application in diagnosis.miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway.Serum WFA(+) -M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis.Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy.Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.Serum WFA+ -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection.The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy.Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C.Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatmentSerum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Could Not Always Predict Early Cirrhosis in Non-Viral Liver Diseases.Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study.Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disordersMac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease.High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues.Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patients.Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B.Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury.Serum levels of Wisteria floribunda agglutinin-positive Mac-2 binding protein reflect the severity of chronic pancreatitis.Hepatic stellate cells secreting WFA+ -M2BP: Its role in biological interactions with Kupffer cells.Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin-positive Mac-2-binding protein in chronic hepatitis C.A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements
P2860
Q27728015-F14E0520-0E14-49FC-9818-97802FEDA0D9Q37226309-9848E7EA-B993-4419-8E20-CF0825A349E6Q38543883-7CA4408C-BF37-48C0-BE80-639085D7261AQ38724173-88D54A52-8709-4B41-B07C-7E034A5EC218Q40244120-CFA3BF84-3DA3-4743-89D5-4A6B7B871AC5Q40513639-5D1CBD1E-A7FB-4452-8EEF-7E532164A42EQ40582320-9490F64A-6E12-404F-86DD-5C4152CF46E8Q40701776-7253E9DE-425A-40B3-9E6F-EDFAF3343844Q40722284-C44E89B7-B3BA-44DB-8487-2D9BBD571427Q40735572-33DF1ECC-8CD1-47F8-8F18-F8F0124E0094Q40936469-90649FD3-64EE-4519-9F31-265D4A7C1313Q41471144-BA05BA4B-C882-4D24-A104-51783B30D098Q41933128-49DEAB0E-0933-4A55-85B3-71EF18F623A3Q42049084-73DE1117-93CB-42E4-B958-E245ADC07689Q42680423-BE2FBE2F-D555-4A86-BEA0-E6850D3E3FE8Q47215149-7DE5CE8F-642E-4E41-84B5-8D758111BC0CQ47223995-D362A33A-89DE-489D-B788-4A6D0B695C83Q47243952-A12ACC77-0073-4CA6-9EB1-C237286137BFQ47286873-BBB1961E-7ADE-4339-B81C-5AAA657911F3Q47890590-E211E441-EB76-4B26-A25C-50BDD52C9E34Q48183214-680636D2-B2BA-4192-81EE-F740DE65CD03Q51049727-2E292094-5968-4578-B714-C97AAF8A6C8FQ51240926-473F760E-200F-4DDA-BF34-2EF4FB99F338Q53123382-41827224-32BD-49E2-A949-DD0ABEE2B3E9Q58712117-B4F5FA7C-1ECC-4152-A283-8194A8537DF6
P2860
Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Clinicopathological characteri ...... s in hepatocellular carcinoma.
@en
type
label
Clinicopathological characteri ...... s in hepatocellular carcinoma.
@en
prefLabel
Clinicopathological characteri ...... s in hepatocellular carcinoma.
@en
P2093
P2860
P1476
Clinicopathological characteri ...... s in hepatocellular carcinoma.
@en
P2093
Akinobu Taketomi
Hepatitis Glyco-biomarker Study Group
Hideki Yokoo
Hirofumi Kamachi
Masaaki Korenaga
Masanori Gotoh
Masashi Mizokami
Masato Fujiyoshi
Moto Fukai
Toshiya Kamiyama
P2860
P304
P356
10.1007/S00535-015-1063-2
P577
2015-03-15T00:00:00Z